Cargando…

Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis

BACKGROUND: Migraine prevention guidelines recommend oral prophylactic medications for patients with frequent headache. This study examined oral migraine preventive medication (OMPM) treatment patterns by evaluating medication persistence, switching, and re-initiation in patients with chronic migrai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hepp, Zsolt, Dodick, David W, Varon, Sepideh F, Chia, Jenny, Matthew, Nitya, Gillard, Patrick, Hansen, Ryan N, Devine, Emily Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405847/ https://www.ncbi.nlm.nih.gov/pubmed/27837173 http://dx.doi.org/10.1177/0333102416678382

Ejemplares similares

EHMTI-0032. Persistence and switching characteristics among chronic migraine patient population: a retrospective claims analysis
por: Hepp, Z, et al.
Publicado: (2014)

Systematic Review of Migraine Prophylaxis Adherence and Persistence
por: Hepp, Zsolt, et al.
Publicado: (2014)

Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
por: Keyloun, Katelyn R., et al.
Publicado: (2017)

Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)
por: Lipton, Richard B, et al.
Publicado: (2015)

Prophylactic treatment of vestibular migraine()
por: Salmito, Márcio Cavalcante, et al.
Publicado: (2016)

Advances in topiramate as prophylactic treatment for migraine
por: Hu, Chuan, et al.
Publicado: (2021)

The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients
por: Rendas-Baum, Regina, et al.
Publicado: (2012)

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale
por: Lipton, Richard B., et al.
Publicado: (2017)

Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine
por: Shaik, Munvar Miya, et al.
Publicado: (2015)

Migraine and risk of stroke
por: Øie, Lise R, et al.
Publicado: (2020)

Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data
por: Dodick, David W., et al.
Publicado: (2020)

The disease burden of migraine patients receiving prophylactic treatments in Korea: a population-based claims database analysis
por: Park, Seonyoung, et al.
Publicado: (2022)

Sleep changes during prophylactic treatment of migraine
por: Duman, Taşkın, et al.
Publicado: (2015)

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014)

Headache-related health resource utilisation in chronic and episodic migraine across six countries
por: Sanderson, Joanna C, et al.
Publicado: (2013)

EHMTI-0099. Migraineur perception regarding family burden from chronic migraine: results of the CAMEO (chronic migraine epidemiology & outcomes) study
por: Buse, DC, et al.
Publicado: (2014)

Optimizing prophylactic treatment of migraine: Subtypes and patient matching
por: Dib, Michel
Publicado: (2008)

Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
por: Yang, Min, et al.
Publicado: (2011)

Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary
por: Lipton, Richard B., et al.
Publicado: (2021)

Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière’s disease or migraine-associated vertigo?
por: TEGGI, R., et al.
Publicado: (2010)

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
por: Rothrock, John F, et al.
Publicado: (2014)

Migraine headache is present in the aura phase – a prospective study
por: Hansen, JM, et al.
Publicado: (2013)

Prophylactic treatment of migraine; the patient's view, a qualitative study
por: Dekker, Frans, et al.
Publicado: (2012)

Prophylactic treatments of migraine and GPs in the north of France: evaluation of practices
por: Christian, CL
Publicado: (2013)

Application and efficacy of levetiracetam in prophylactic treatment of migraine without aura
por: Maykova, TN
Publicado: (2013)

Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
por: Papetti, Laura, et al.
Publicado: (2019)

Evaluation of body composition in patients with migraine on prophylactic treatment with topiramate
por: Caverni, Camila Naegeli, et al.
Publicado: (2021)

Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers
por: MacGregor, Anne
Publicado: (2013)

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
por: Aurora, Sheena, et al.
Publicado: (2011)

Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study
por: Munjal, Sagar, et al.
Publicado: (2019)

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
por: Lipton, Richard B, et al.
Publicado: (2016)

Targeting TRP Channels For Novel Migraine Therapeutics
por: Dussor, Gregory, et al.
Publicado: (2014)

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine
por: Rendas-Baum, Regina, et al.
Publicado: (2014)

The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence
por: Gollion, Cedric, et al.
Publicado: (2022)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines
por: Dima, Lorena, et al.
Publicado: (2019)

Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine
por: Teggi, R., et al.
Publicado: (2014)

Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
por: Tatsumoto, Muneto, et al.
Publicado: (2022)

Migraines and keloids: a 15-year Taiwan claim database analysis
por: Lu, Ying-Yi, et al.
Publicado: (2022)

The Prevalence of Migraine With Anxiety Among Genders
por: Karimi, Leila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l9f1u66uggur153trvcf8tcck3